Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Method for fabricating black silicon by using plasma immersion ion implantation
Apparatus and method for conveying audio signals from an input locus to an output locus
Recording material post-processing device and recording material processing apparatus using the same
Remote configuration of a hardware setting on one or more target computing device(s)
Absorbent article package
Messaging in mobile telecommunications networks
Notifying a UL/DL configuration in LTE TDD systems
  Randomly Featured Patents
Hierarchical CRC scheme
Alpha halo substituted asymmetrical diacyl peroxides in co-initiator systems
Systems and methods for enterprise software management
Air sampling method and sensor system for spectroscopic detection and identification of chemical and biological contaminants
Arc welding torch having integrated wire feed
Automated pipe clearing apparatus
System and method for financial transactions in a rideshare environment
Comb generators
Analyte detection system
Charged-particle source, control system, and process using gating to extract the ion beam